This includes vegetarians, those with prolonged breastfeeding even if the mother has sufficient vitamin D levels, individuals on exclusion diets (e.g., milk allergy), those with malabsorption, celiac and inflammatory bowel disease, liver and renal diseases, and those using certain drugs (e.g., anticonvulsants, anti-tuberculosis drugs, glucocorticoids, and some antifungal drugs).
The clinical manifestations of vitamin D deficiency primarily include rickets in growing children and osteomalacia in adolescents and adults (
5). In our study, 15% of children exhibited poor weight gain and failure to thrive, and 12% had anemia. Only one patient showed clinical evidence of rickets (
6). None of these children displayed signs or symptoms related to bone and joint diseases, and nearly 15% came for checkups and follow-ups (
7). There were no biochemical changes such as reduced calcium and phosphorus, so no further workup was conducted. Efforts focused on providing sufficient vitamin D intake — 400 IU (10 micrograms) daily for infants and 600 IU (15 micrograms) for those aged 1 - 18 years (
8). For high-risk populations, such as those in Mediterranean and Middle Eastern regions, northern latitudes, and children on anticonvulsants, glucocorticoid therapy, and HIV medications, up to 2000 IU/day of vitamin D may be necessary to raise 25(OH)D levels to > 30 ng/mL (75 nmol/L) (
9).
In Shiraz, a very warm city with plenty of sunshine year-round, children are less likely to go outdoors during the day in spring and summer due to the very hot weather, resulting in reduced sun exposure.